Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
10.99
+0.51 (4.87%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Ardent Health Revenue
Ardent Health had revenue of $1.62B in the quarter ending June 30, 2026, a decrease of -1.40%. This brings the company's revenue in the last twelve months to $6.41B, up 3.34% year-over-year. In the year 2025, Ardent Health had annual revenue of $6.32B with 6.01% growth.
Revenue (ttm)
$6.41B
Revenue Growth
+3.34%
P/S Ratio
0.24
Revenue / Employee
$254,204
Employees
25,200
Market Cap
1.55B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.32B | 358.27M | 6.01% |
| Dec 31, 2024 | 5.97B | 556.59M | 10.29% |
| Dec 31, 2023 | 5.41B | 279.80M | 5.45% |
| Dec 31, 2022 | 5.13B | 259.29M | 5.32% |
| Dec 31, 2021 | 4.87B | 708.52M | 17.02% |
| Dec 31, 2018 | 4.16B | 1.16B | 38.63% |
| Dec 31, 2017 | 3.00B | 896.86M | 42.60% |
| Dec 31, 2016 | 2.11B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| agilon health | 5.92B |
| Astrana Health | 3.84B |
| AMN Healthcare Services | 3.43B |
| Surgery Partners | 3.37B |
| Healthcare Services Group | 1.86B |
| The Pennant Group | 1.10B |
| InnovAge Holding | 949.17M |
| Nutex Health | 846.72M |
ARDT News
- 12 days ago - Oklahoma Heart Institute brings new cardiovascular trials, tech to patients - TheFly
- 12 days ago - Oklahoma Heart Institute Brings New National Cardiovascular Trials and Technologies to Patients Across the Region - Business Wire
- 13 days ago - Ardent Health price target raised to $10 from $9 at BofA - TheFly
- 17 days ago - Ardent Health price target raised to $13 from $11 at Goldman Sachs - TheFly
- 17 days ago - Ardent Health price target raised to $13 from $12 at Truist - TheFly
- 17 days ago - Ardent Health price target raised to $13 from $12 at Mizuho - TheFly
- 17 days ago - Ardent Health price target raised to $14 from $13 at Guggenheim - TheFly
- 18 days ago - Ardent Health Earnings Call Transcript: Q2 2026 - Transcripts